- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
U.S. Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
4
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
4 companies
BioStem Technologies
Market Cap: US$118.8m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$7.10
7D
23.5%
1Y
-35.6%
Puma Biotechnology
Market Cap: US$253.9m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$5.04
7D
1.0%
1Y
101.6%
SIGA Technologies
Market Cap: US$600.8m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$8.39
7D
-3.6%
1Y
-7.1%
Gyre Therapeutics
Market Cap: US$703.0m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$7.74
7D
-5.6%
1Y
-43.8%